GSWM
RMD icon

Golden State Wealth Management’s ResMed RMD Stock Holding History

Golden State Wealth Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.48K Hold
33
– – ﹤0.01% 1210
2026
Q1 		$7.45K Hold
33
– – ﹤0.01% 1143
2025
Q4 		$7.97K Hold
33
– – ﹤0.01% 1162
2025
Q3 		$9.03K Hold
33
– – ﹤0.01% 1124
2025
Q2 		$8.51K Hold
33
– – ﹤0.01% 1113
2025
Q1 		$7.39K Hold
33
– – ﹤0.01% 1083
2024
Q4 		$7.55K Buy
+33
New +$7.95K ﹤0.01% 1023

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Golden State Wealth Management's RMD Position: Q2 2026 in Review

Golden State Wealth Management held its ResMed (RMD) position steady in Q2 2026 at 33 shares worth $6.48K. The position accounts for ﹤0.01% of the portfolio, ranked #1210.

Golden State Wealth Management first reported a position in RMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $9.03K in Q3 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Golden State Wealth Management held 33 shares of ResMed worth $6.48K as of Q2 2026.
  • Golden State Wealth Management left its ResMed share count unchanged in Q2 2026.
  • ResMed made up ﹤0.01% of Golden State Wealth Management's portfolio in Q2 2026, its #1210 holding.
  • Golden State Wealth Management first reported a position in ResMed in Q4 2024 and has held it in 7 quarters since.
  • Golden State Wealth Management's ResMed position peaked at $9.03K in Q3 2025.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Golden State Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.